Post job

Idera Pharmaceuticals overview

Industry
Biotechnology
Revenue
Headquarters
Employees
36
Founded in
Website
Organization type
Public
Social media
Idera Pharmaceuticals, Inc., a biotechnology company, discovers and develops DNA- and RNA-based drug candidates for the treatment of infectious diseases, autoimmune and inflammatory diseases, cancer, and asthma and allergies, and for use as vaccine adjuvants. The company designs and creates proprietary Toll-Like Receptors (TLR) to modulate immune responses, including TLR agonist, a compound that stimulates an immune response through the targeted TLR; and TLR antagonist, a compound that blocks activation of an immune response through the targeted TLR. Its drug candidates include IMO-2125, a TLR9 agonist, which is in Phase 1 clinical trial for hepatitis C virus infection; and TLR7, 8, and 9 agonists that are in research stage for viral diseases. The company also develops IMO-3100, a dual TLR7/TLR9 antagonist, which is in preclinical development stage for autoimmune and inflammatory diseases, such as lupus, rheumatoid arthritis, multiple sclerosis, psoriasis, and colitis. In addition, its drug candidates also comprise TLR7 and TLR8 agonists that are in research stage for solid tumor cancers. The company has a licensing and collaboration agreement with Merck KGaA to research, develop, and commercialize TLR9 agonists for the treatment of cancer, excluding cancer vaccines; a license and research collaboration agreement with Merck & Co., Inc. to research, develop, and commercialize therapeutic and prophylactic vaccine products containing its TLR7, 8, and 9 agonists in the fields of cancer, infectious diseases, and Alzheimer's disease; and a research collaboration and option agreement, and a license, development, and commercialization agreement with Novartis International Pharmaceutical, Ltd. to discover, develop, and commercialize TLR9 agonists for the treatment of asthma and allergies. The company was founded in 1989 and is based in Cambridge, Massachusetts.
The average employee at Idera Pharmaceuticals makes $56,901 per year. Pay at Idera Pharmaceuticals is significantly lower than some of its highest paying competitors, like Gilead Sciences, Coherus BioSciences, and Biogen, which pay $99,828, $92,640, and $92,036, respectively.
Idera Pharmaceuticals is a small health care company based in Cambridge, MA with only 36 employees and an annual revenue of $4.9M.

Idera Pharmaceuticals's mission statement

To translate scientific breakthroughs into important new medicines. We have a culture where patients are at the center of all we do, with core Idera values that connect us to each other and our stakeholders and define who we are, what we stand for, and how we work.

In demand companies are hiring! Let Zippia apply for you!

Floating question marks illustration
-

Idera Pharmaceuticals employee reviews

Be the first to review!

Do you work at Idera Pharmaceuticals?

Help job seekers learn about working at Idera Pharmaceuticals

On this page

Be the first to review Idera Pharmaceuticals

Anonymously rate your employee experience

Your opinion can help other job seekers

Do you like working at Idera Pharmaceuticals?

The team at Idera Pharmaceuticals

  • The key people at Idera Pharmaceuticals is Vincent J. Milano.
Key people
Vincent J. Milano

Idera Pharmaceuticals salaries

Average Idera Pharmaceuticals salary
$56,901
yearly
$27.36 hourly
Updated March 14, 2024

Rate Idera Pharmaceuticals' commitment to diversity and inclusion.

Zippia waving zebra

Do you work at Idera Pharmaceuticals?

Were you satisfied with Idera Pharmaceuticals' salary and benefits?

Idera Pharmaceuticals financial performance

3.9
Performance score

We calculated the performance score of companies by measuring multiple factors, including revenue, longevity, and stock market performance.

Idera Pharmaceuticals currently has 4.9M in revenue. Idera Pharmaceuticals's most recent quarter produced 2.5m (q1'2023).

Idera Pharmaceuticals annual revenue

$35M
$28M
$21M
$14M
$7M
$0
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2022

Highest paying Idera Pharmaceuticals competitors

Compare Idera Pharmaceuticals salaries to competitors, including Gilead Sciences, Coherus BioSciences, and Biogen. Employees at Gilead Sciences earn the highest average yearly salary of $99,828. The salaries at Coherus BioSciences average $92,640 per year, and the salaries at Biogen come in at $92,036 per year.
RankCompanyAverage salaryJobs
1$99,8280
2$92,6400
3$92,0360
4$89,1360
5$74,1180
6$70,9140
7$49,2790
8$48,7520
9$46,4580
10$45,0490

Are you an executive, HR leader, or brand manager at Idera Pharmaceuticals?

Claiming and updating your company profile on Zippia is free and easy.

Idera Pharmaceuticals FAQs

Search for jobs

Zippia gives an in-depth look into the details of Idera Pharmaceuticals, including salaries, political affiliations, employee data, and more, in order to inform job seekers about Idera Pharmaceuticals. The employee data is based on information from people who have self-reported their past or current employments at Idera Pharmaceuticals. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by Idera Pharmaceuticals. The data presented on this page does not represent the view of Idera Pharmaceuticals and its employees or that of Zippia.

Idera Pharmaceuticals may also be known as or be related to IDERA PHARMACEUTICALS INC., IDERA PHARMACEUTICALS Inc, Idera Pharmaceuticals, Idera Pharmaceuticals Inc and Idera Pharmaceuticals, Inc.